Managing stress and trauma is difficult at any time for those with substance use disorders. COVID-19 has only intensified the challenge. Isolation and financial burdens can drive patients with substance use disorders to engage in risky behavior or potentially relapse. What can you do as their pharmacist? Plenty. Join this session to explore how trauma and stress might affect your patients and how you can help them safely cope.
At the completion of this knowledge-based activity, participants will be able to:
- Describe the impact that coronavirus disease 2019 (COVID-19) induced stress and trauma might have on patients diagnosed with a substance use disorder (SUD).
- Identify strategies to help patients with SUD cope with COVID-19–induced stress and trauma without relapse or increasing substance misuse.
- Describe how pharmacists can assist patients who are in recovery or struggling with SUD during the COVID-19 pandemic.
Activity type: Knowledge-based
Target Audience: Pharmacists
Learning Level: 2
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following archived webinar is approved for 1 contact hour of CPE credit (0.1 CEU). The ACPE Universal Activity Number for this activity is 0202-0000-21-046-H04-P
To obtain credit for From Stress to Substance Abuse: Helping Your Patients Through a Pandemic, participants are required to watch the archived webinar, complete the evaluation, and then CLAIM credit. Participants need to have a valid pharmacist.com and CPE Monitor/NABP ID account to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.Initial release date: March 11, 2021
Expiration date: March 11, 2024 - No credit granted after this date
From Stress to Substance Abuse: Helping Your Patients Through a Pandemic is an activity for pharmacists developed by the American Pharmacists Association. © 2021 American Pharmacists Association
Speaker disclosures will be provided at the time of the seminar, and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures.
Conflicts of interest have been resolved through content review by Helen Sairany, BA, PharmD, MBA, BCACP, Director of Content Development & Partnership at the American Pharmacists Association.
This learning product is a component of the APhA Symposium on Substance Use Disorder and Patient Well-Being: Exploring the Mental Health Conditions Associated With Substance Use Disorders Package.
Computer and internet access are required to complete this activity. Please visit our website to view the Technology System Requirements in order to have a positive learning experience.